Understanding how mitochondrial protection helps neurons in Parkinson's disease
Compensatory Mitochondrial Protective Mechanisms Against Oxidative Stress in PD
This study is looking at how a special protein called PKD1 helps protect brain cells from damage in Parkinson's disease, with the hope that understanding this process can lead to new ways to support people living with the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-11124750 on NIH RePORTER |
What this research studies
This research investigates the protective mechanisms that neurons use to combat oxidative stress in Parkinson's disease (PD). It focuses on a specific protein, PKD1, which is activated during early oxidative damage to help protect dopamine-producing neurons. By using cell and animal models, the study aims to uncover how PKD1 influences mitochondrial and nuclear functions to enhance neuron survival. The findings could lead to new insights into the progression of PD and potential therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's disease, particularly those experiencing early symptoms.
Not a fit: Patients with advanced Parkinson's disease or those with other neurodegenerative disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance neuronal survival and slow the progression of Parkinson's disease.
How similar studies have performed: Previous research has shown promising results in understanding mitochondrial protection mechanisms in neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Kanthasamy, Anumantha Gounder — University of Georgia
- Study coordinator: Kanthasamy, Anumantha Gounder
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.